Bhooshitha B. de Silva
Corporate Officer/Principal chez PPD, INC.
Profil
Bhooshitha B.
de Silva is currently working as the SVP & Global Head-Development & Strategy at Pharmaceutical Product Development LLC and as the Senior VP-Corporate Development & Strategy at PPD, Inc. Previously, Bhooshitha held positions as a Director at Lifesci Acquisition II Corp., an Independent Director at Science 37 Holdings, Inc. from 2021 to 2024, and as the VP, Head-Business Development & Strategy at Pfizer Inc. from 2000 to 2011.
Bhooshitha also served as the VP-Development & Head-International at Optimer, Inc. from 2011 to 2014 and as the Vice President-Business Development & Strategy at Optimer Pharmaceuticals LLC from 2011 to 2013.
Bhooshitha obtained a graduate degree from Stanford University in 2000, a graduate degree from Imperial College London in 1995, and a graduate degree from the London School of Economics & Political Science in 1997.
Postes actifs de Bhooshitha B. de Silva
| Sociétés | Poste | Début |
|---|---|---|
| PPD, INC. | Corporate Officer/Principal | 01/01/2014 |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Corporate Officer/Principal | 01/01/2014 |
Anciens postes connus de Bhooshitha B. de Silva
| Sociétés | Poste | Fin |
|---|---|---|
| SCIENCE 37 HOLDINGS, INC. | Directeur/Membre du Conseil | 12/03/2024 |
Optimer, Inc.
 Optimer, Inc. Miscellaneous Commercial ServicesCommercial Services Optimer, Inc. operates materials research, development and testing laboratory. The company was founded in 1993 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 01/01/2014 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2011 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | - |
| SCIENCE 37 HOLDINGS, INC. | Directeur/Membre du Conseil | - |
Formation de Bhooshitha B. de Silva
| Imperial College London | Graduate Degree |
| London School of Economics & Political Science | Graduate Degree |
| Stanford University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SCIENCE 37 HOLDINGS, INC. | Commercial Services |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Lifesci Acquisition II Corp.
 Lifesci Acquisition II Corp. Financial ConglomeratesFinance LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York, NY. | Finance |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Optimer, Inc.
Optimer, Inc. Miscellaneous Commercial ServicesCommercial Services Optimer, Inc. operates materials research, development and testing laboratory. The company was founded in 1993 and is headquartered in Chicago, IL. | Commercial Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
